,i  #aagth ,,congress  #ast ,session    
,h4 ,r4 #ebgj  ,,in ,,the ,,house ,,of  
,,representatives  ,september #ag1      
#bjba,mr4 ,carter of ,georgia 7for      
himself1 ,mr4 ,cuellar1 and ,mr4        
,gallagher7 introduced the following    
bill2 which was referred to the         
,committee on ,energy and ,commerce  ,a 
,,bill  ,to prohibit the ,national      
,institutes of ,health from conducting  
or supporting certain gain-of-function  
research1 and for other purposes4  #a4  
,short title ,this ,act may be cited as 
the ,pausing ,enhanced ,pandemic        
,pathogen ,research ,act of #bjba4  #b4 
,no conduct or support by ,,nih of      
gain-of-function research ,part ,a of   
title ,,iv of the ,public ,health       
,service ,act 7#db ,u4,s4,c4 #bha et    
seq47 is amended by adding at the end   
the following3  #djd,o4                 
,gain-of-function research  7a7         
,prohibition ,during the period ending  
on ,september #cj1 #bjbf1 the ,national 
,institutes of ,health shall not conduct

 or support1 directly or indirectly1    
including through subgrants1 any        
gain-of-function research that may be   
reasonably anticipated to confer        
attributes to any influenza virus or    
coronavirus 7including any coronavirus  
that is associated with severe acute    
respiratory syndrome7 such that the     
virus would have enhanced pathogenicity 
or transmissibility in mammals via the  
respiratory route4  7b7 ,limitation     
,this section does not apply to         
characterization or testing of any      
naturally occurring influenza virus or  
coronavirus1 unless the characterization
 or testing is anticipated to increase  
pathogenicity or transmissibility4  4